Manni Mohyuddin: The results of the GEM-CESAR trial are a stunning verdict against early intervention in SMM
Manni Mohyuddin shared on X:
“The GEM-CESAR trial of a super aggressive approach to SMM (KRD>Transplant>KR>Len) just got published.
The results are a stunning verdict against early intervention in SMM, despite the way the results are potrayed. Here is a peer review and critical appraisal of this.”
Authors: María-Victoria Mateos, Joaquin Martínez-López, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Oriol, Norma C. Gutiérrez, Rafael Ríos-Tamayo, Laura Rosiñol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrián Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier De La Rubia, Ana Isabel Teruel, Felipe de Arriba, Luis Palomera, Miguel T. Hernández, Javier Lopez Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique M. Ocio, Bruno Paiva, Noemi Puig, M. Teresa Cedena, Joan Bladé, Juan Jose Lahuerta, Jesus F. San-Miguel
Source: Manni Mohyuddin/X
Dr. Manni Mohyuddin is an Assistant Professor at the Huntsman Cancer Institute, University of Utah, specializing in oncology. He is mainly interested in myeloma, supportive care, end-of-life management, and implementing cost-effective, evidence-based treatment strategies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023